Details for Patent: 9,458,195
✉ Email this page to a colleague
Which drugs does patent 9,458,195 protect, and when does it expire?
Patent 9,458,195 protects IMCIVREE and is included in one NDA.
This patent has sixty-two patent family members in twenty countries.
Summary for Patent: 9,458,195
Title: | Melanocortin receptor ligands |
Abstract: | The present invention is directed to compounds according to formula, (R.sup.2R.sup.3)-A.sup.1-c(A.sup.2-A.sup.3-A.sup.4-A.sup.5-A.sup.6-A.sup.- 7-A.sup.8-A.sup.9)-A.sup.10-R.sup.1, and pharmaceutically-acceptable salts thereof that act as ligands for one or more of the melanocortin receptors, to methods of using such compounds to treat mammals and to pharmaceutical compositions comprising said compounds. |
Inventor(s): | Dong; Zheng Xin (Holliston, MA), Moreau; Jacques-Pierre (Upton, MA) |
Assignee: | Ipsen Pharma S.A.S. (Boulogne-Billancourt, FR) |
Application Number: | 13/074,565 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 9,458,195
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,458,195
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2236151 | ⤷ Sign Up | 301150 | Netherlands | ⤷ Sign Up |
European Patent Office | 2236151 | ⤷ Sign Up | CA 2021 00053 | Denmark | ⤷ Sign Up |
European Patent Office | 2236151 | ⤷ Sign Up | 2021C/557 | Belgium | ⤷ Sign Up |
European Patent Office | 2236151 | ⤷ Sign Up | 122021000084 | Germany | ⤷ Sign Up |
European Patent Office | 2236151 | ⤷ Sign Up | CR 2021 00053 | Denmark | ⤷ Sign Up |
European Patent Office | 2236151 | ⤷ Sign Up | 52/2021 | Austria | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |